Nebenwirkungen · Entyvio
Entyvio 300 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 8
HOS-129646 · Präparat HOS-096773
The following listing of adverse reactions is based on clinical trial and post marketing experience and is displayed by system organ class. Within the system organ classes, adverse reactions are listed under headings of the following frequency categories: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), very rare (< 1/10 000) and not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-03T09:14:00Z · SHA-256 3d6ba3681a1d0775f0244dea2efe5bbcd88dbb2a6c736f41490947f42cd86c3e · Passage bb83bff619f9b39c5bdefa48ad5ff0686fa22fa1434047390d2ba368a5eb8ff3 · Zeichen 548–1070 im Abschnitt